CSIMarket
 


Lexaria Bioscience Corp   (LXRP)
Other Ticker:  
 
 

LXRP's Operating Income Growth by Quarter and Year

Lexaria Bioscience 's Operating Income results by quarter and year




LXRP Operating Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter August - -1.09 -1.22 0.21
III Quarter May -1.39 -1.18 -3.42 -0.33
II Quarter February -1.00 -1.15 -1.36 -0.45
I Quarter November -0.92 -0.70 -0.58 -0.13
FY   -3.31 -4.12 -6.58 -0.70



LXRP Operating Income third quarter 2020 Y/Y Growth Comment
Lexaria Bioscience Corp in the third quarter recorded Operating Loss of $ -1.39 millions.

According to the results reported in the third quarter, Lexaria Bioscience Corp achieved the best Operating Income growth in Legal Marijuana industry. While Lexaria Bioscience Corp ' s Operating Income no change of % ranks overall at the positon no. in the third quarter.

Explain Operating Income growth


LXRP Operating Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter August - - - -
III Quarter May - - - -
II Quarter February - - - -
I Quarter November - - - -
FY   - - - -

Financial Statements
Lexaria Bioscience 's third quarter 2020 Operating Income $ -1.39 millions LXRP's Income Statement
Lexaria Bioscience 's third quarter 2019 Operating Income $ -1.18 millions Quarterly LXRP's Income Statement
New: More LXRP's historic Operating Income Growth >>


LXRP Operating Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter August - - - -
III Quarter May - - - -
II Quarter February - - - -
I Quarter November - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Legal Marijuana Industry #
Consumer Non Cyclical Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Legal Marijuana Industry #
Consumer Non Cyclical Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Lexaria Bioscience 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LXRP's III. Quarter Q/Q Operating Income Comment
III. Quarter 2020 accomplishment of -1.39 millions by Lexaria Bioscience Corp come out even less good compare to the -1.00 millions in the second quarter.

Within Legal Marijuana industry Lexaria Bioscience Corp achieved highest sequential Operating Income growth. While Lexaria Bioscience 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Legal Marijuana Industry #
Consumer Non Cyclical Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Legal Marijuana Industry #
Consumer Non Cyclical Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LXRP's III. Quarter Q/Q Operating Income Comment
III. Quarter 2020 results of -1.39 millions by Lexaria Bioscience Corp look even less good if you take a look at -1.00 millions Operating Loss in the second quarter.

Within Legal Marijuana industry Lexaria Bioscience Corp achieved highest sequential Operating Income growth. While Lexaria Bioscience 's Operating Income growth quarter on quarter, overall rank is .


Lexaria Bioscience 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(May 31 2020)
12 Months Ending
(Feb 29 2020)
12 Months Ending
(Nov 30 2019)
12 Months Ending
(Aug 31 2019)
12 Months Ending
(May 31 2019)
Cumulative Operating Income 12 Months Ending $ -4.40 $ -4.19 $ -4.35 $ -4.13 $ -4.25
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Lexaria Bioscience Corp ' has realized cumulative trailing twelve months Operating Loss of $ -4 millions in the May 31 2020 period.
The results are detiriorating as the cumulative Operating Loss is becoming larger from $ -4.19 millions for the period from Feb 29 2020 to May 31 2019 and $ -1 millions for the twelve months ending in the quarter May 31 2019.

Lexaria Bioscience Corp achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Legal Marijuana Industry #
Consumer Non Cyclical Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Lexaria Bioscience Corp ' has realized cumulative trailing twelve months Operating Loss of $ -4 millions in the May 31 2020 period.
The situation is detiriorating as the cumulative Operating Loss is becoming larger from $ -4.19 millions for the period from Feb 29 2020 to May 31 2019 and $ -1 millions from the TTM period ending May 31 2019.

Lexaria Bioscience Corp achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Legal Marijuana Industry #
Consumer Non Cyclical Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Legal Marijuana Industry Operating Income Growth Trends and Statistics
Consumer Non Cyclical Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
LXRP's Operating Income Growth Ratio versus Legal Marijuana Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for LXRP's Competitors
Operating Income Growth for Lexaria Bioscience 's Suppliers
Operating Income Growth for LXRP's Customers

You may also want to know
LXRP's Annual Growth Rates LXRP's Profitability Ratios LXRP's Asset Turnover Ratio LXRP's Dividend Growth
LXRP's Roe LXRP's Valuation Ratios LXRP's Financial Strength Ratios LXRP's Dividend Payout Ratio
LXRP's Roa LXRP's Inventory Turnover Ratio LXRP's Growth Rates LXRP's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending May 31 2020 within Consumer Non Cyclical SectorY/Y Change %Operating Income for the quarter ending May 31 2020
Mccormick and Co Inc  23.69 %$ 23.691 millions
General Mills Inc   15.84 %$ 15.836 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AERO's Profile

Stock Price

AERO's Financials

Business Description

Fundamentals

Charts & Quotes

AERO's News

Suppliers

AERO's Competitors

Customers & Markets

Economic Indicators

AERO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright Š 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071